22.10SEK-2.00%Mkt Cap: 62.42M $P/E: 52.621d ago
EQL Pharma AB (publ) engages in the development, marketing, and sale of generic medicines to pharmacies and hospitals in Sweden, Denmark, Norway, Finland, and the rest of Europe. It offers injection products for inpatien…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap62.42M $
Enterprise Value—
Revenue (TTM)3.05M $
Gross Profit15.58M $
Net Income (TTM)1.20M $
Revenue/Share1.401 USD
Last Price22.10 SEK
Fiscal Year EndMar 2026
MR QuarterMar 2018
Employees60
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINSE0005497732
Valuation
P/E (Trailing)52.62
P/E (Forward)7.06
PEG—
EV/EBITDA—
EV/Revenue—
P/S20.50
P/B2.44
EPS (TTM)0.42
EPS (Forward)3.13
52W Range
21.351% of range108.80
52W High108.80 SEK
52W Low21.35 SEK
Profitability
Gross Margin37.64%
Oper. Margin-16.73%
EBITDA Margin1.60%
Profit Margin2.90%
ROE4.69%
ROA1.47%
Growth
Revenue Growth21.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF2.71M $
CapEx (TTM)6.43M $
FCF Margin-69.16%
FCF Yield-3.37%
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity1.82
Current Ratio2.84
Quick Ratio—
Book Value/Sh9.044 SEK
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)50.00 SEK
Upside (mean)+126.2%
Target Range50.00 SEK – 50.00 SEK
# Analysts1
Ownership
Shares Out.29.53M
Float11.75M
Insiders61.09%
Institutions16.24%
Technical
SMA 5025.88 (-14.6%)
SMA 20048.13 (-54.1%)
Beta—
S&P 52W Chg19.63%
Avg Vol (30d)30.72K
Avg Vol (10d)23.51K
Technical Indicators
RSI (14)31.5
MACD-1.2064
MACD Signal-1.3977
MACD Hist.+0.1913
BB Upper25.28 SEK
BB Middle23.62 SEK
BB Lower21.96 SEK
BB Width14.08%
ATR (14)1.426 SEK
Vol Ratio (20d)0.80x